ACLS Provider: Course

Incorrect. Amiodarone is used after defibrillation and epinephrine for refractory VF to stabilize the myocardium.

Incorrect. With an advanced airway in place, compressions should continue uninterrupted while providing 10 breaths per minute.

Incorrect. Indicates effective chest compressions and blood circulation during resuscitation.

Incorrect. Adenosine is administered as a rapid IV push to terminate SVT in pediatric patients, followed by a saline flush.

Incorrect. Epinephrine 1 mg IV/IO is administered every 3-5 minutes during cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. A PETCO2 reading above 10 mmHg indicates adequate chest compressions and cardiac output during CPR.

Incorrect. Epinephrine is dosed at 0.01 mg/kg IV/IO during pediatric cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. Amiodarone is administered as a 300 mg IV/IO bolus for refractory VF or pulseless VT.

Incorrect. A compression fraction >80% is required to maximize perfusion and improve survival rates during high-quality CPR.

Incorrect. Epinephrine is given at a dose of 1 mg IV/IO every 3-5 minutes during adult cardiac arrest to improve perfusion.

Incorrect. Delivering 10 breaths per minute ensures adequate oxygenation without causing hyperventilation.

Incorrect. Hypoxia is one of the most common reversible causes of PEA and is addressed with high-quality oxygenation during resuscitation.

Incorrect. Defibrillation is the primary treatment for pulseless VT, aiming to restore organized cardiac activity.

Incorrect. Positioning the patient with a slight left tilt prevents aortocaval compression and improves venous return during CPR.

Incorrect. Epinephrine is given as a continuous infusion to maintain adequate heart rate and perfusion when atropine is ineffective.

Incorrect. PETCO2 monitoring ensures effective ventilation and provides feedback on the quality of chest compressions during CPR.

Incorrect. CPR is the primary treatment for PEA, along with epinephrine and addressing reversible causes to restore circulation.

Incorrect. The jaw-thrust avoids neck movement, making it the preferred airway technique for patients with suspected cervical spine injuries.

Incorrect. Epinephrine at 1 mg IV every 3-5 minutes is used to enhance perfusion during cardiac arrest.

Incorrect. Biphasic defibrillation begins at 120-200 J to terminate shockable rhythms like VF and pulseless VT effectively.

Incorrect. Biphasic defibrillators deliver effective shocks within the range of 120-200 J, restoring organized electrical activity.

Incorrect. Asystole is a non-shockable rhythm requiring high-quality CPR and epinephrine administration.

Incorrect. Waveform capnography provides real-time confirmation of ET tube placement and ensures proper ventilation.

Incorrect. With an advanced airway in place, uninterrupted compressions improve blood flow while ventilation is delivered separately.

Incorrect. For biphasic defibrillators, 120-200 J is the recommended energy range for VF.

Incorrect. Atrial fibrillation is cardioverted starting at 120-200 J in synchronized mode to avoid delivering the shock during ventricular repolarization.

Incorrect. TTM prevents further neurological injury by maintaining a controlled core temperature after ROSC.

Incorrect. Rescuers should switch roles every 2 minutes to maintain high-quality chest compressions and prevent fatigue.

Incorrect. Ventilations are delivered every 6-8 seconds to provide oxygenation without interrupting chest compressions.

Incorrect. While hypoglycemia can cause critical symptoms, it is not included in the H's and T's of reversible causes of cardiac arrest.

Incorrect. VF is a shockable rhythm requiring immediate defibrillation to restore organized electrical activity.

Incorrect. Needle decompression relieves pressure caused by tension pneumothorax, improving ventilation and circulation.

Incorrect. Ventricular fibrillation presents as a disorganized rhythm that requires immediate defibrillation.

Incorrect. Rhythm checks should be performed every 2 minutes during CPR, coinciding with compressor role switches.

Incorrect. Atropine doses should not exceed 3 mg during bradycardia management to avoid adverse effects.

Incorrect. Rescuers should switch every 2 minutes to prevent fatigue and ensure high-quality compressions are maintained.

Incorrect. For adult CPR, the ratio ensures adequate perfusion and oxygenation when no advanced airway is in place.

Incorrect. Dopamine is used to improve heart rate and contractility in bradycardia unresponsive to atropine.

Incorrect. Magnesium sulfate stabilizes the cardiac membrane and is the drug of choice for treating torsades de pointes.

Incorrect. Vagal maneuvers stimulate the vagus nerve, often terminating narrow-complex SVT caused by reentrant circuits.

Incorrect. PEA is not a shockable rhythm; it is managed with high-quality CPR and addressing the underlying reversible causes.

Incorrect. Adenosine is used for narrow-complex SVT, not wide-complex tachycardia, which is typically treated with amiodarone.

Incorrect. Epinephrine is administered every 3-5 minutes during pediatric cardiac arrest to enhance coronary and cerebral perfusion.

Incorrect. Atropine is the first-line treatment for symptomatic bradycardia, increasing the heart rate by blocking vagal stimulation.

Incorrect. Calling for help ensures timely assistance and access to advanced resuscitation equipment.

Incorrect. Avoid delays to minimize interruptions in chest compressions and maintain perfusion.

Incorrect. Synchronized cardioversion is used for unstable atrial fibrillation to restore organized electrical activity.

Incorrect. Synchronized cardioversion is the treatment of choice for unstable ventricular tachycardia with a pulse.

Incorrect. Magnesium sulfate is administered to stabilize the myocardium and treat torsades de pointes effectively.

Incorrect. PEA is not treated with adenosine; it is managed with CPR, epinephrine, and identifying and treating reversible causes.

Incorrect. Epinephrine is given first in VF during cardiac arrest, followed by amiodarone as an antiarrhythmic after defibrillation attempts.

Incorrect. Post-ROSC care focuses on maintaining oxygenation and avoiding hypoxia or hyperoxia to protect organ function.

Incorrect. A compression fraction >80% ensures that the majority of CPR time is spent delivering chest compressions to improve outcomes.

Incorrect. The initial dose of adenosine for stable SVT in adults is 6 mg IV, followed by 12 mg if needed for subsequent doses.

Incorrect. Asystole is a non-shockable rhythm requiring immediate high-quality CPR and administration of epinephrine.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and should be treated with warming measures.

Incorrect. First-line treatment to block vagal stimulation and increase heart rate.

Incorrect. Hypokalemia can cause cardiac arrhythmias and is included in the "H's" of reversible causes of cardiac arrest.

Incorrect. Pediatric defibrillation starts at 2 J/kg, increasing to 4 J/kg for subsequent shocks if needed.

Incorrect. Provides external electrical stimuli to maintain adequate heart rate when atropine fails.

Incorrect. Early defibrillation within 30 seconds of a witnessed VF arrest increases survival rates significantly.

Incorrect. A left lateral tilt prevents aortocaval compression, improving venous return and cardiac output during resuscitation.

Incorrect. Asystole is not a shockable rhythm; it is treated with high-quality CPR and epinephrine.

Incorrect. Adenosine is the first-line drug for treating narrow-complex SVT by slowing conduction through the AV node.

Incorrect. A 30:2 ratio ensures sufficient oxygenation and circulation in adults during CPR without an advanced airway.